Cachet Pharmaceutical Co Ltd Market Cap ($457.59 Million)

$457.59 Million USD  · CN¥3.13 Billion CNY  · Rank #12338

Market Cap & Net Worth: Cachet Pharmaceutical Co Ltd (002462)

Cachet Pharmaceutical Co Ltd market cap. Cachet Pharmaceutical Co Ltd (SHE:002462) has a market capitalization of $457.59 Million (CN¥3.13 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #12338 globally and #3505 in its home market, demonstrating a -6.78% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cachet Pharmaceutical Co Ltd's stock price CN¥10.72 by its total outstanding shares 291707120 (291.71 Million). Also see 002462 cash flow conversion for how efficiently the company converts equity into cash flow.

Cachet Pharmaceutical Co Ltd Market Cap History (2015–2026)

Cachet Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows change from $1.85 Billion to $457.59 Million (-10.38% CAGR). Check Cachet Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Cachet Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Cachet Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 002462 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.03x

Cachet Pharmaceutical Co Ltd's market cap is 0.03 times its annual revenue

Industry average: 0.13x Lower than industry average

Latest Price to Earnings (P/E) Ratio

5.50x

Cachet Pharmaceutical Co Ltd's market cap is 5.50 times its annual earnings

Industry average: 1.12x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $1.57 Billion $10.97 Billion $223.10 Million 0.14x 7.02x
2017 $962.86 Million $14.24 Billion $263.64 Million 0.07x 3.65x
2018 $538.52 Million $17.96 Billion $327.63 Million 0.03x 1.64x
2019 $603.25 Million $22.19 Billion $375.96 Million 0.03x 1.60x
2020 $546.44 Million $23.26 Billion $317.59 Million 0.02x 1.72x
2021 $558.40 Million $25.63 Billion $353.88 Million 0.02x 1.58x
2022 $586.56 Million $26.22 Billion $296.94 Million 0.02x 1.98x
2023 $592.50 Million $30.00 Billion $250.06 Million 0.02x 2.37x
2024 $551.50 Million $24.02 Billion $160.67 Million 0.02x 3.43x
2025 $612.97 Million $19.53 Billion $111.38 Million 0.03x 5.50x

Competitor Companies of 002462 by Market Capitalization

Companies near Cachet Pharmaceutical Co Ltd in the global market cap rankings as of November 1, 2026. Also see Cachet Pharmaceutical Co Ltd (002462) total assets for a full breakdown of the balance sheet.

Key companies related to Cachet Pharmaceutical Co Ltd by market ranking:

  • JD HEALTH INTL LTD (F:8ZN): Ranked #1867 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
  • Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2108 globally with a market cap of $10.37 Billion USD.
  • ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2442 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
  • Raia Drogasil S.A (SA:RADL3): Ranked #3350 globally with a market cap of $5.22 Billion USD ( R$26.61 Billion BRL).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#1867 JD HEALTH INTL LTD F:8ZN $12.04 Billion €4.30
#2108 Walgreens Boots Alliance Inc NASDAQ:WBA $10.37 Billion $11.98
#2442 ALIB.HL.INF.TEC.UNSP.ADR F:TWYA $8.42 Billion €8.95
#3350 Raia Drogasil S.A SA:RADL3 $5.22 Billion R$15.22

Market Capitalization of Cachet Pharmaceutical Co Ltd (2015–2026)

Market capitalization of Cachet Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Cachet Pharmaceutical Co Ltd's market cap moved from $1.85 Billion to $ 457.59 Million, with a yearly change of -10.38%.

Year Market Cap Change (%)
2026 CN¥457.59 Million -25.35%
2025 CN¥612.97 Million +11.15%
2024 CN¥551.50 Million -6.92%
2023 CN¥592.50 Million +1.01%
2022 CN¥586.56 Million +5.04%
2021 CN¥558.40 Million +2.19%
2020 CN¥546.44 Million -9.42%
2019 CN¥603.25 Million +12.02%
2018 CN¥538.52 Million -44.07%
2017 CN¥962.86 Million -38.54%
2016 CN¥1.57 Billion -15.38%
2015 CN¥1.85 Billion --

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of Cachet Pharmaceutical Co Ltd was reported to be:

Source Market Cap
Yahoo Finance $457.59 Million USD
MoneyControl $457.59 Million USD
MarketWatch $457.59 Million USD
marketcap.company $457.59 Million USD
Reuters $457.59 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Cachet Pharmaceutical Co Ltd

SHE:002462 China Pharmaceutical Retailers
Market Cap
$457.59 Million
CN¥3.13 Billion CNY
Market Cap Rank
#12338 Global
#3505 in China
Share Price
CN¥10.72
Change (1 day)
-6.54%
52-Week Range
CN¥10.72 - CN¥19.12
All Time High
CN¥44.79
About

Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical drugs, medical devices, e-commerce products, and warehousing logistics services. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.